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Background
KSHV, also called human herpesvirsus-8 (HHV8), is the
etiologic agent of primary effusion lymphoma (PEL)
(including extracavitary variant), and large B-cell lym-
phoma arising in HHV8-associated multicentric Castle-
man disease (together, KSHV-associated non-Hodgkin
lymphoma (KSHV-NHL). Additional KSHV-associated
diseases include: Kaposi sarcoma (KS), a form of multi-
centric Castleman disease (KSHV-MCD), and a proposed
KSHV-associated inflammatory cytokine syndrome
(KICS). Like KSHV-MCD, inflammatory symptoms are
common in KSHV-NHL. We compared an array of
inflammatory and angiogenic cytokines, chemokines,
growth factors, and select clinical laboratory values
between HIV-infected patients with KSHV-NHL and
other lymphomas (HIV-lymphoma).
Methods
Patients were enrolled in HAMB and/or NIAID protocols.
Cases had KSHV-NHL; controls other HIV-lymphoma.
Clonality of PEL diagnosed from effusions was confirmed
by PCR for immunoglobin rearrangements. Serum was
evaluated by ELISA for IFN-g, IL-1b, IL-6, IL-8, IL-10, IL-
12p70, TNF-a, IL-17, VEGF-A, (Meso-Scale Discovery,
Gathersberg, MD), CXCL1, VEGF-C (R&D Systems, Min-
neapolis, MN). In patients with KSHV-NHL, peripheral
blood mononuclear cell associated KSHV viral load was
measured. Clinical data included demographics, CD4
count, albumin, platelets, hemoglobin, and c-reactive pro-
tein (CRP). Comparison of each parameter between
patients with KSHV-NHL and other HIV-lymphoma
employed an exact form of the Wilcoxon rank-sum test.
P-values are 2-sided, with p ≤ 0.01 considered statistically
significant, and 0.01< p <0.05 considered strong trends.
Results
Subjects:13 KSHV-NHL cases: 12 men, 1 woman. Median
age 44, (IQR 39-55). 4 white, 4 Hispanic, 3 African-Ameri-
can, 2 African. PEL (8), extracavitary variant PEL (3), large
B-cell lymphoma arising in HHV8-associated MCD (2,
both with large effusions), history pathology confirmed
KSHV-MCD (4). 28 HIV-associated lymphoma controls:
23 men, 5 women. Median age 38 (IQR 35-46). 17 white,
4 Hispanic, 6 African-American, 1 African. Histologies:
primary central nervous system lymphoma (13), diffuse
large B-cell lymphoma (DLBCL) (10), Hodgkin disease (1),
Burkitt lymphoma (2), plasmablastic lymphoma (1), EBV+
large B-cell lymphoma NOS (1). KSHV-NHL subjects had
elevated KSHV viral load, [median 2812 copies/10
6 cells
(IQR 186-115,789)] and CRP [median 51 mg/L (IQR 45-
67)]. Compared to other HIV-lymphomas, patients with
KSHV-NHL have higher CD4 counts (median CD4 133
vs. 29 cells/uL, p=0.002), hypoalbuminema (median albu-
min 1.9 vs. 3.5 mg/dL, p= 0.0034)), and trend towards
more severe anemia, thrombocytopenia, and hyponatre-
mia. KSHV-NHL is associated with elevated circulating
KSHV, marked elevations in IL-10 (513 vs. 12.2 pg/mL,
p <0.0001), elevations in IL-6 (29 vs. 4.1 pg/mL,
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any medium, provided the original work is properly cited.p=0.0013), IL-17 (1.6 vs. 0.5 pg/mL, p=0.0074), and trends
towards increased IFN-g and IL-1b.
Conclusions
Inflammatory cytokines are important n KSHV-NHL
pathogenesis and symptomatology. Clinical and transla-
tional studies evaluating these abnormalities in KSHV-
associated malignancies are ongoing.
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